HEARTBROKEN parents have told of their grief following the sudden death of their son after running a half marathon aged just ...

Biomedical engineers have developed an AI-based platform that designs short proteins, termed peptides, capable of binding and destroying previously undruggable disease-causing proteins. Inspired by ...

Biomedical engineers at Duke University have developed an AI-based platform that designs short proteins, termed peptides, capable of binding and destroying previously undruggable disease-causing ...

Eldiara Doucette, a TikTok star who details her journey with rare cancer synovial sarcoma online, shared a lighthearted ...

Nagpur: In a remarkable achievement, AIIMS Nagpur successfully treated a 26-year-old MBBS student suffering from synovial cell sarcoma, a rare and aggressive cancer affecting the chest wall. The young ...

Under the agreement, AGC Biologics will manufacture the lentiviral vector used to produce lete-cel, an engineered T-cell therapy targeting the NY-ESO-1 antigen. This support will include activities ...

Adaptimmune CEO Adrian Rawcliffe said during the JP Morgan Healthcare Conference on Tuesday that the firm expects to begin the process of submitting a rolling biologics license application to the FDA ...

Adaptimmune Therapeutics in August 2024 secured FDA approval for the first engineered T cell therapy for solid tumor cancers in the U.S. Tecelra is also the first new therapeutic option for synovial ...